Direkt zum Inhalt
Merck
  • Fatal sodium valproate-induced hypersensitivity syndrome with lichenoid dermatitis and fulminant hepatitis.

Fatal sodium valproate-induced hypersensitivity syndrome with lichenoid dermatitis and fulminant hepatitis.

Journal of the American Academy of Dermatology (2003-08-02)
Yau-Li Huang, Hong-Shang Hong, Zen-Whe Wang, Tseng-tong Kuo
ZUSAMMENFASSUNG

Anticonvulsant hypersensitivity syndrome caused by sodium valproate (Depakene) has rarely been reported. Here we describe a patient who presented with nonspecific polymorphous eruptions, fulminant hepatitis, and jaundice. Lichenoid dermatitis was found in the skin biopsy specimen. Toxic hepatitis and microvesicular steatosis were found in the liver biopsy specimen, consistent with valproate hepatotoxicity.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Valproinsäure, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
2-Propylpentansäure
Supelco
Valproic acid solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®